glp 1 and kidneys GLP-1 receptor agonists next-generation metabolic hormone therapies in chronic kidney disease Glucagon-like peptide-1 receptor agonists in
Description
Three new #GLP-1 drugs for obesity treatment2 injectables and 1 pillmay receive FDA approval this year
The prevalence of type 2 diabetes (T2D) is increasing worldwide, with many patients developing long-term complications that affect their cardiovascular, urin...
President Trump hailed his deal with pharma companies on GLP-1 drug pricing
GLP-1 receptor agonists typically do not cause ongoing soft stools or diarrhea after discontinuation, as their gastrointestinal effects generally resolve whe...
The PatchAid Berberine Patch delivers a plant-based formula straight through your skin
The New York pharma giant said Thursday it will ...
